Faheem Hasnain at Endpoints' #BIO22 panel (J.T. MacMillan Photography for Endpoints News)
Faheem Hasnain forges a $120M private placement. So what did we learn from that?
This morning Faheem Hasnain is unveiling a $120 million private placement for his biotech, Gossamer Bio. Which says a lot about where and how the …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.
